Biotech company looking for money
Building on the success from April’s seminar, Medicon Valley Alliance in cooperation with DNB invites you to participate in a second network meeting on how to attract investors and industry partners to a life science company. At the meeting you will also have the opportunity to present your technology / business plan to any of the cooperating partners in a 1-1 setting.
Attracting interest from investors and industry partners lies at the core of most successful life science ventures. In the current funding environment, where there is simply not enough capital available to fund all the promising projects, these processes are more important than ever: Success in creating investor/partner interest is likely to distinguish the future winners from those companies that will not be given the chance to exploit the full potential of their technologies/products.
Hear Lubor Gaal describe how BMS looks at licensing, Eugen Steiner from HealthCap shed light on the venture capitalists’ point of view, and ex-entrepreneur Øyvind W. Brekke discuss how DNB as a bank can play a role even for early-stage companies.
Following the presentations, you will have the opportunity to discuss your technology / business plan to any of the presenters in 1-1 meetings.
Date & Time: Tuesday 11 December 2012, 9:00-11:30 (1-1 meetings until 16:00)
Venue: Arne Jacobsens Allé 15-17, 2300 Copenhagen S, Denmark
MVA members free of charge (no-show/late cancellation fee DKK 1.000 ex VAT)
Non-members DKK 1.500 ex. VAT (become a member here)
Will be invoiced prior to the seminar.
Register: To register please go to the bottom of this page.
In collaboration with:
09.00-09.30 Registration and networking
09.30-10.00 Partnering with BMS
Lubor Gaal, Head of Europe, Search & Evaluation, Search Transaction Group, Bristol-Myers Squibb
10.00-10.30 What HealthCap looks for when investing in venture-stage companies
Dr. Eugen Steiner, MD, PhD, partner of HealthCap
10.30-10.50 How DNB as a bank can add value in the pre-commercial development stage
Øyvind W. Brekke, Senior Advisor, Section International Healthcare, DNB
11.00-16.00 1-1 meetings / networking / lunch
Learn More: Biotech company looking for money